Stock Events

Stock Events

Creo Medical Group 

GBX10.88
35
+GBX0.13+1.16% Tuesday 16:05

Statistics

Day High
11
Day Low
10.75
52W High
18.5
52W Low
9.22
Volume
406,669
Avg. Volume
-
Mkt Cap
35.27M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25MayExpected
Q1 2023
Q2 2023
Q1 2024
Q2 2024
Q1 2025
Q2 2025
Next
-2.84
-1.88
-0.92
0.04
Expected EPS
N/A
Actual EPS
N/A

Financials

-93.49%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
6.14BRevenue
-5.74BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CREO.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation offers medical solutions that compete directly with Creo Medical's advanced energy devices, particularly in the field of minimally invasive surgeries.
Medtronic
MDT
Mkt Cap111.22B
Medtronic plc provides a wide range of medical technologies, including surgical devices that rival Creo Medical's offerings in energy-based surgical and therapeutic solutions.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson, through its medical devices segment, competes in the same space as Creo Medical by offering a variety of surgical instruments and medical equipment.
Intuitive Surgical
ISRG
Mkt Cap160.56B
Intuitive Surgical, Inc. specializes in robotic-assisted surgery, competing with Creo Medical's focus on minimally invasive surgical technologies.
Smith & Nephew
SNN
Mkt Cap13.72B
Smith & Nephew plc manufactures medical equipment for surgery, which competes with Creo Medical's surgical devices, especially in the areas of wound management and endoscopy.
Stryker
SYK
Mkt Cap126.97B
Stryker Corporation is a direct competitor in the medical technology field, offering surgical equipment and medical devices that challenge Creo Medical's product range.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. competes with Creo Medical in the development and marketing of surgical solutions and orthopedic devices.
Baxter International
BAX
Mkt Cap8.61B
Baxter International Inc. provides a broad range of medical devices that compete with Creo Medical's offerings, particularly in the areas of critical care and surgery.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories offers medical devices and healthcare solutions that compete across several of Creo Medical's key areas, including vascular therapy and minimally invasive surgeries.
Edwards Lifesciences
EW
Mkt Cap47.07B
Edwards Lifesciences Corporation is a competitor in the field of medical technology, focusing on products for surgical and critical care, which overlaps with Creo Medical's market.

About

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a microwave ablation device designed for soft tissue ablation; and SpydrBlade Flex, a multi-modal endoscopic scissor-type device. In addition, it provides endotherapy accessories comprising injection needles, haemostatic clips, snares, and forceps, as well as other products for gastroenterology, pulmonology, and urology. Further, the company offers products for diagnostic, therapeutic, and hygiene purposes. Creo Medical Group PLC was founded in 2003 and is headquartered in Chepstow, the United Kingdom.
Show more...
CEO
Mr. Craig Jonathan Gulliford
Employees
129
Country
GB
ISIN
GB00BZ1BLL44

Listings

LSE
GB
CREO.LSE
F
DE
1RC.F
OTC Link
US
CMEOF

0 Comments

Share your thoughts

FAQ

What is Creo Medical Group stock price today?▼
The current price of CREO.LSE is GBX10.88 GBX — it has increased by +1.16% in the past 24 hours. Watch Creo Medical Group stock price performance more closely on the chart.
What is Creo Medical Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Creo Medical Group stocks are traded under the ticker CREO.LSE.
Is Creo Medical Group stock price growing?▼
CREO.LSE stock has risen by +0% compared to the previous week, the month change is a -19.44% fall, over the last year Creo Medical Group has showed a +0% increase.
What is Creo Medical Group market cap?▼
Today Creo Medical Group has the market capitalization of 35.27M
When is the next Creo Medical Group earnings date?▼
Creo Medical Group is going to release the next earnings report on May 25, 2026.
What were Creo Medical Group earnings last quarter?▼
CREO.LSE earnings for the last quarter are 0.04 GBX per share, whereas the estimation was N/A GBX resulting in a N/A surprise. The estimated earnings for the next quarter are N/A GBX per share.
What is Creo Medical Group revenue for the last year?▼
Creo Medical Group revenue for the last year amounts to 6.14B GBX.
What is Creo Medical Group net income for the last year?▼
CREO.LSE net income for the last year is -5.74B GBX.
How many employees does Creo Medical Group have?▼
As of April 08, 2026, the company has 129 employees.
In which sector is Creo Medical Group located?▼
Creo Medical Group operates in the Health Care sector.
When did Creo Medical Group complete a stock split?▼
Creo Medical Group has not had any recent stock splits.
Where is Creo Medical Group headquartered?▼
Creo Medical Group is headquartered in Chepstow, GB.